Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that ...
The addition of glucose-dependent insulinotropic polypeptide (GIP) to semaglutide for 6 weeks did not improve glycemic control in people with type 2 diabetes (T2D), new research found. “Our main ...
GIP respectivelyke the dual agonist GP-1/GIP require the GIP receptor in the brain to reduce body weight and food intake. Source: Helmholtz Zentrum München Disclaimer: AAAS and EurekAlert! are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results